
Driving Stability and Efficiency Through Quality Management Maturity
March 12, 2025
by Aron Yaeger, Principal Consultant & Quality Practice Area Leader, Enterey Life Sciences Consulting
Rather than waiting for the FDA to finalize a Quality Management Maturity (QMM) model, pharma organizations should adopt standardized QMM frameworks proactively, as they foster cross-functional quality ownership and provide many other benefits. In this post, Enterey explains why regular QMM self-assessments make good business sense. Learn how to develop a QMM approach that enforces quality standards, protects patients, and supports business success as regulations and expectations evolve throughout the product lifecycle.
Full story